Focus On Abbott Labs Remains On Pending Deals
July 21, 2016 at 14:28 PM EDT
Qualifying the second quarter results of Abbott Laboratories (NYSE: ABT) as solid, UBS indicated the focus of investors is now on the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.